Biocon Biologics gains full gobal rights to biosimilar Adalimumab Ruchika Sharma23 Dec 2025 12:30 PM ISTBengaluru: Biocon Biologics, a fully integrated global biosimilars company and subsidiary of Biocon, has announced that it has secured full and...
USFDA issues EIR for Biocon Generics Cranbury facility Ruchika Sharma19 Dec 2025 11:30 AM ISTBengaluru: Biocon has announced that the Company has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated...
Biocon Biologics recognized as Asia IP Elite for 2025 by IAM Ruchika Sharma17 Dec 2025 12:00 PM ISTBengaluru: Biocon Biologics, a fully integrated global biosimilars company and subsidiary of Biocon has announced that it has been recognized as...
Biocon Chief Kiran Mazumdar-Shaw wins USC Business Management Award Ruchika Sharma15 Dec 2025 2:30 PM ISTBengaluru: Kiran Mazumdar-Shaw, Founder and Chairperson, Biocon Group has been honored with the prestigious USC Business Management Award, at the...
Biocon unveils Liraglutide for diabetes, obesity in Netherlands Ruchika Sharma15 Dec 2025 12:14 PM ISTBengaluru: Biocon Limited, a global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for diabetes (gVictoza) and...
Biocon Biologics signs settlement, license agreement to commercialize biosimilar Aflibercept worldwide Ruchika Sharma14 Dec 2025 4:30 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced a new settlement...
S&P Global places Biocon Biologics on positive CreditWatch on account of accelerated debt reduction Ruchika Sharma11 Dec 2025 3:30 PM ISTBengaluru: Biocon Biologics Limited, a fully integrated, global biosimilars company and subsidiary of Biocon Ltd. has announced that S&P...
Biocon to make Biocon Biologics a wholly owned arm Ruchika Sharma6 Dec 2025 1:27 PM ISTBengaluru: Biocon Limited, a global biopharmaceuticals company, has announced a strategic corporate action to fully integrate Biocon Biologics...
Biocon Pharma gains tentative USFDA nod for Parkinson's disease capsules Ruchika Sharma6 Dec 2025 11:30 AM ISTBengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received tentative approval from...
Biocon Biologics secures market entry date for Denosumab biosimilars in Europe, Rest of World Ruchika Sharma2 Dec 2025 11:38 AM ISTBengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced a settlement...
Biocon Biologics Bengaluru facility classified as VAI by USFDA Ruchika Sharma27 Nov 2025 11:33 AM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (FDA) CDER-OC, Office of Manufacturing Quality, has classified Biocon...
India well positioned to evolve as innovation led pharma nation over next 5 years: CDSCO Ruchika Sharma26 Nov 2025 12:29 PM ISTNew Delhi: India is well-positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five...
